Joshua L. Roffman MD, MMSc is an Associate Professor of Psychiatry at Harvard Medical School, Co-Director for Psychiatric Neuroimaging at Massachusetts General Hospital (MGH), and Director of Research for the MGH Schizophrenia Clinical and Research Program. He received his BA (neuroscience) from Amherst College, his MD from the University of Maryland School of Medicine, and MMSc from Harvard Medical School. Following residency training in adult psychiatry at MGH and McLean Hospital and postdoctoral training in brain imaging and genetics at MGH, he established the Brain Genomics Laboratory within the MGH Department of Psychiatry, a multidisciplinary research program that merges imaging (MRI, PET), genomics, and clinical trials. His current work, which is supported by NIMH, MQ: Transforming Mental Health, and NARSAD/Brain and Behavior Research Foundation, focuses on folate-based interventions and altered dopamine signaling in schizophrenia.

Following residency training in adult psychiatry at MGH and McLean Hospital and postdoctoral training in brain imaging and genetics at MGH, he established the Brain Genomics Laboratory within the MGH Department of Psychiatry, a multidisciplinary research program that merges imaging (MRI, PET), genomics, and clinical trials. His current work, which is supported by NIMH, MQ: Transforming Mental Health, and NARSAD/Brain and Behavior Research Foundation, focuses on folate-based interventions and altered dopamine signaling in schizophrenia.